Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$36.7K
6.50K shares
What this filing means
SWARTZ ROBIN plans to sell 6.50K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $36.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/23/2024ACC: 0001959173-24-008802
Officer· Chief Operating Officer
Since Feb 2022
6.50K
Shares to sell
$36.7K
Approx. market value
6.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/17/2024
3.97KRestricted Stock Vesting
Compensation
4/1/2023
2.53KTotal acquired6.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2024 | Restricted Stock Vesting Compensation | 3.97K | — |
4/1/2023 | Restricted Stock Vesting Compensation | 2.53K | — |
| Total | 6.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.50K
Market value
$36.7K
12/23/2024
Total
Units
6.50K
Value
$36.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/23/2024 | 6.50K | $36.7K | NASDAQ | Planned |
| Total | 6.50K | $36.7K | ||